To include your compound in the COVID-19 Resource Center, submit it here.

In a rare M&A move, Amgen proposes to acquire partner Nuevolution

In what would be its first acquisition since 2015, Amgen offered on Wednesday to buy Copenhagen-based small molecule discovery company Nuevolution for about $167 million in cash.

Amgen Inc. (NASDAQ:AMGN)

Read the full 294 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers